Title:
METHODS FOR TREATING NEUROPSYCHIATRIC DISORDERS WITH NMDA RECEPTOR ANTAGONISTS
Document Type and Number:
WIPO Patent Application WO2002045710
Kind Code:
A9
Abstract:
The present invention relates to compositions and methods for treating a human patient afflicted with a neuropsychiatric disorder. Specifically, the invention provides for compositions and methods of modulating or antagonizing the activity of neuronal NMDA receptors, wherein such antagonistic activity is capable of modulating the glutamate induced excitatory response of the neurons, thereby inhibiting an excitotoxic effect, promoting a neurotrophic effect, and thereby providing a therapeutic effect that treats the neuropsychiatric disorder.
More Like This:
| JP2006328079 | COMPOSITION STIMULATING SPECIFIC METALLOENZYME |
| WO/2021/069890 | TREATMENT OF OSTEOPENIA AND/OR OSTEOPOROSIS |
| JP2009539881 | Substituted phenylacetic acid as a DP-2 antagonist |
Inventors:
LIPTON STUART M D (US)
Application Number:
PCT/US2001/048516
Publication Date:
April 24, 2003
Filing Date:
December 07, 2001
Export Citation:
Assignee:
NEUROMOLECULAR INC (US)
LIPTON STUART M D (US)
LIPTON STUART M D (US)
International Classes:
A61K45/00; A61K31/00; A61K31/13; A61P25/00; A61P25/18; A61P25/22; A61P25/24; A61P25/36; A61P43/00; (IPC1-7): A61K31/13
Download PDF:
Previous Patent: USE OF ZWITTERIONIC POLYSACCHARIDES FOR THE SPECIFIC MODULATION OF IMMUNE PROCESSES
Next Patent: NOVEL METHOD AND USE
Next Patent: NOVEL METHOD AND USE